Rtw Investments »

Axogen shares owned by Rtw Investments

Quarter-by-quarter ownership of Axogen (AXGN) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Axogen

Tip: Access up to 7 years of quarterly data

All positions including Axogen held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axogen by Rtw Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $47M 1.0M 46.19

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Argenx Se Sponsored Adr (ARGX)
Ptc Therapeutics I (PTCT)
Protagonist Therapeutics (PTGX)
Cg Oncology (CGON)
Insmed Com Par $.01 (INSM)
Tango Therapeutics (TNGX)
Spyre Therapeutics Com New (SYRE)
Celcuity (CELC)
Erasca (ERAS)
RadNet (RDNT)
Oruka Therapeutics (ORKA)
Natera (NTRA)
Ultragenyx Pharmaceutical (RARE)
Irhythm Technologies (IRTC)

View all positions for Rtw Investments

Top funds holding Axogen

BlackRock
Morgan Stanley
First Light Asset Management
Vanguard Capital Management
Polar Capital Holdings
Artemis Investment Management
Wellington Management Company
Citadel Advisors
Geode Capital Management
Daniel D. Thurber
Goldman Sachs Group
FMR
State Street Corporation
Hood River Capital Management
Assenagon Asset Management

View all funds holding Axogen